A detailed history of Kennedy Capital Management, Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 261,640 shares of LIVN stock, worth $13.1 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
261,640
Previous 274,029 4.52%
Holding current value
$13.1 Million
Previous $15 Million 8.55%
% of portfolio
0.32%
Previous 0.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.38 - $54.59 $537,434 - $676,315
-12,389 Reduced 4.52%
261,640 $13.7 Million
Q2 2024

Aug 14, 2024

SELL
$51.76 - $64.15 $1.69 Million - $2.1 Million
-32,676 Reduced 10.65%
274,029 $15 Million
Q1 2024

May 15, 2024

SELL
$48.6 - $57.12 $241,833 - $284,229
-4,976 Reduced 1.6%
306,705 $17.2 Million
Q4 2023

Feb 14, 2024

BUY
$43.45 - $53.66 $460,700 - $568,956
10,603 Added 3.52%
311,681 $16.1 Million
Q3 2023

Nov 14, 2023

BUY
$50.12 - $58.87 $44,506 - $52,276
888 Added 0.3%
301,078 $15.9 Million
Q2 2023

Aug 14, 2023

BUY
$42.28 - $51.43 $3.67 Million - $4.46 Million
86,784 Added 40.67%
300,190 $15.4 Million
Q1 2023

May 15, 2023

SELL
$40.84 - $58.14 $184,147 - $262,153
-4,509 Reduced 2.07%
213,406 $9.3 Million
Q4 2022

Feb 14, 2023

SELL
$43.88 - $56.16 $305,536 - $391,042
-6,963 Reduced 3.1%
217,915 $12.1 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $1.67 Million - $2.29 Million
34,480 Added 18.11%
224,878 $11.4 Million
Q2 2022

Aug 10, 2022

BUY
$57.25 - $86.63 $2.32 Million - $3.52 Million
40,578 Added 27.08%
190,398 $11.9 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $5.85 Million - $7.17 Million
82,418 Added 122.28%
149,820 $12.3 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $435,002 - $525,495
5,670 Added 9.18%
67,402 $5.89 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $4.69 Million - $5.47 Million
61,732 New
61,732 $4.89 Million
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $335,767 - $397,809
-4,572 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$62.9 - $82.41 $133,410 - $174,791
-2,121 Reduced 31.69%
4,572 $337,000
Q4 2020

Feb 12, 2021

SELL
$46.01 - $68.74 $5.18 Million - $7.74 Million
-112,557 Reduced 94.39%
6,693 $443,000
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $863,220 - $1.19 Million
-20,597 Reduced 14.73%
119,250 $5.39 Million
Q2 2020

Aug 14, 2020

BUY
$39.87 - $56.9 $246,077 - $351,186
6,172 Added 4.62%
139,847 $6.73 Million
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $819,295 - $1.83 Million
-23,942 Reduced 15.19%
133,675 $6.05 Million
Q4 2019

Feb 14, 2020

SELL
$68.92 - $85.27 $2.58 Million - $3.19 Million
-37,443 Reduced 19.2%
157,617 $11.9 Million
Q3 2019

Nov 14, 2019

BUY
$71.74 - $86.35 $4.16 Million - $5.01 Million
58,042 Added 42.36%
195,060 $14.4 Million
Q2 2019

Aug 14, 2019

SELL
$66.45 - $97.36 $12.6 Million - $18.4 Million
-189,134 Reduced 57.99%
137,018 $9.86 Million
Q1 2019

May 13, 2019

SELL
$86.15 - $100.49 $1.91 Million - $2.23 Million
-22,199 Reduced 6.37%
326,152 $31.7 Million
Q4 2018

Feb 12, 2019

SELL
$84.14 - $125.42 $7.51 Million - $11.2 Million
-89,264 Reduced 20.4%
348,351 $31.9 Million
Q3 2018

Nov 14, 2018

BUY
$101.02 - $130.95 $1.57 Million - $2.03 Million
15,526 Added 3.68%
437,615 $54.3 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $10.2 Million - $13.1 Million
124,297 Added 41.74%
422,089 $42.1 Million
Q1 2018

May 14, 2018

SELL
$79.95 - $89.74 $1.11 Million - $1.24 Million
-13,840 Reduced 4.44%
297,792 $26.4 Million
Q4 2017

Feb 13, 2018

BUY
$71.8 - $88.21 $6.17 Million - $7.58 Million
85,913 Added 38.06%
311,632 $24.9 Million
Q3 2017

Nov 13, 2017

BUY
$60.32 - $70.06 $13.6 Million - $15.8 Million
225,719
225,719 $15.8 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.69B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.